Future directions in regional treatment strategies for melanoma and sarcoma

G. M. Beasley, M. I. Ross, Douglas Tyler

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

Hyperthermic isolated limb perfusion (HILP) with melphalan and more recently isolated limb infusion (ILI) with melphalan +/- dactinomycin are common treatment modalities for both in-transit melanoma of the extremity and advanced extremity sarcoma. In order to further optimize treatment, future research should focus on selection of appropriate patients, verification of a technique that produces consistent results while maintaining acceptable toxicity, and development of novel strategies and agents. Development of these novel agents and strategies has potential to not only improve the efficacy of regional chemotherapy but may also help guide future strategies for systemic treatment.

Original languageEnglish (US)
Pages (from-to)301-309
Number of pages9
JournalInternational Journal of Hyperthermia
Volume24
Issue number3
DOIs
StatePublished - May 2008
Externally publishedYes

    Fingerprint

Keywords

  • Melanoma
  • Regional chemotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Radiological and Ultrasound Technology

Cite this